Datasets:

---

sarus-tech

/

phee

like 2

Follow

Sarus Technologies 10

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"development\"]], \"start\": [[90]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"protamine hypersensitivity\"]], \"start\": [[105]], \"entity_id\": [\"T4\"]}, \"Subject\": {\"text\": [[\"Patients\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"neutral protamine Hagedorn (NPH) insulin\"]], \"start\": [[19]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"neutral protamine Hagedorn (NPH) insulin\"]], \"start\": [[19]], \"entity_id\": [\"T7\"]}}, \"Severity\": {\"text\": [[\"increased risk\"]], \"start\": [[67]], \"entity_id\": [\"T8\"], \"value\": \"Medium\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[24]], \"entity_id\": [\"T6\"]}, \"Subject\": {\"text\": [[\"The second patient\"]], \"start\": [[0]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"cholestasis\", \"duct paucity\"]], \"start\": [[34, 104]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"trimethoprim-sulfamethoxazole\"]], \"start\": [[62]], \"entity_id\": [\"T8\"], \"Drug\": {\"text\": [[\"trimethoprim-sulfamethoxazole\"]], \"start\": [[62]], \"entity_id\": [\"T9\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"became\"]], \"start\": [[26]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"hypothyroid\"]], \"start\": [[33]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"ferrous sulfate\"]], \"start\": [[58]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"ferrous sulfate\"]], \"start\": [[58]], \"entity_id\": [\"T7\"]}}, \"Subject\": {\"text\": [[\"a patient\"]], \"start\": [[12]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"to\"]], \"start\": [[8]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Allergy\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"cloxacillin\"]], \"start\": [[11]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"cloxacillin\"], [\"amoxicillin\"], [\"cefuroxime\"]], \"start\": [[11], [48], [64]], \"entity_id\": [\"T6\", \"T7\", \"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[10]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"Triazolam\"]], \"start\": [[0]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"Triazolam\"]], \"start\": [[0]], \"entity_id\": [\"T9\"]}}, \"Effect\": {\"text\": [[\"nocturnal bingeing with amnesia\"]], \"start\": [[18]], \"entity_id\": [\"T7\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[12]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"Ticlopidine\"]], \"start\": [[0]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"Ticlopidine\"]], \"start\": [[0]], \"entity_id\": [\"T9\"]}}, \"Effect\": {\"text\": [[\"aplastic anemia (TIAA)\"]], \"start\": [[20]], \"entity_id\": [\"T7\"]}, \"Speculated\": {\"text\": [[\"uncommon\"]], \"start\": [[62]], \"entity_id\": [\"T8\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"resulted\"]], \"start\": [[104]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"simvastatin and the anticoagulant acenocoumarol\"]], \"start\": [[49]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"simvastatin\"], [\"anticoagulant acenocoumarol\"]], \"start\": [[49], [69]], \"entity_id\": [\"T11\", \"T12\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"and\"]], \"start\": [[61]], \"entity_id\": [\"T13\"]}, \"Drug\": {\"text\": [[\"simvastatin\"], [\"anticoagulant acenocoumarol\"]], \"start\": [[49], [69]], \"entity_id\": [\"T11\", \"T12\"]}}]}, \"Effect\": {\"text\": [[\"elevated INR\"]], \"start\": [[119]], \"entity_id\": [\"T8\"]}, \"Subject\": {\"text\": [[\"One case\"]], \"start\": [[0]], \"entity_id\": [\"T9\"], \"Population\": {\"text\": [[\"One\"]], \"start\": [[0]], \"entity_id\": [\"T10\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"correlated\"]], \"start\": [[49]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"an i.v. regimen of 5-fluorouracil\"]], \"start\": [[63]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"5-fluorouracil\"]], \"start\": [[82]], \"entity_id\": [\"T11\"]}, \"Route\": {\"text\": [[\"i.v.\"]], \"start\": [[66]], \"entity_id\": [\"T12\"]}}, \"Effect\": {\"text\": [[\"neurotoxicity\", \"acute confusional state and abnormalities of symmetrically restricted diffusion in the periventricular white matter and corpus callosum\"]], \"start\": [[35, 112]], \"entity_id\": [\"T7\"]}, \"Subject\": {\"text\": [[\"A 35-year-old woman\"]], \"start\": [[0]], \"entity_id\": [\"T8\"], \"Age\": {\"text\": [[\"35-year-old\"]], \"start\": [[2]], \"entity_id\": [\"T9\"]}, \"Gender\": {\"text\": [[\"woman\"]], \"start\": [[14]], \"entity_id\": [\"T10\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"aggravate\"]], \"start\": [[15]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"Ampicillin\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"Ampicillin\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"myasthenia gravis\"]], \"start\": [[51]], \"entity_id\": [\"T5\"]}, \"Speculated\": {\"text\": [[\"may\"]], \"start\": [[11]], \"entity_id\": [\"T7\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[106]], \"entity_id\": [\"T6\"]}, \"Subject\": {\"text\": [[\"Japanese vivax malaria patient\"]], \"start\": [[43]], \"entity_id\": [\"T3\"], \"Race\": {\"text\": [[\"Japanese\"]], \"start\": [[43]], \"entity_id\": [\"T7\"]}}, \"Treatment\": {\"text\": [[\"halofantrine\"]], \"start\": [[127]], \"entity_id\": [\"T4\"], \"Disorder\": {\"text\": [[\"vivax malaria\"]], \"start\": [[52]], \"entity_id\": [\"T8\"]}, \"Drug\": {\"text\": [[\"halofantrine\"]], \"start\": [[127]], \"entity_id\": [\"T9\"]}}, \"Effect\": {\"text\": [[\"QT interval was prolonged\"]], \"start\": [[80]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"related\"]], \"start\": [[97]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"products containing L-tryptophan\"]], \"start\": [[108]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"L-tryptophan\"]], \"start\": [[128]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"eosinophilia-myalgia syndrome\"]], \"start\": [[67]], \"entity_id\": [\"T4\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[23]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"Disopyramide (Norpace)\"]], \"start\": [[0]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"Disopyramide\"]], \"start\": [[0]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"hypoglycemia\"]], \"start\": [[31]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"treated\"]], \"start\": [[76]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"dapsone\"]], \"start\": [[89]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"dapsone\"]], \"start\": [[89]], \"entity_id\": [\"T7\"]}, \"Disorder\": {\"text\": [[\"brown recluse spider bite\"]], \"start\": [[103]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"hypersensitivity syndrome\"]], \"start\": [[21]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"a patient\"]], \"start\": [[60]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[40]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"piloerection\"]], \"start\": [[27]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"fluvoxamine maleate\"]], \"start\": [[56]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"fluvoxamine maleate\"], [\"milnacipran hydrochloride\"]], \"start\": [[56], [81]], \"entity_id\": [\"T7\", \"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[19]], \"entity_id\": [\"T7\"]}, \"Effect\": {\"text\": [[\"Serotonin syndrome\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"linezolid and meperidine\"]], \"start\": [[37]], \"entity_id\": [\"T8\"], \"Drug\": {\"text\": [[\"linezolid\"], [\"meperidine\"]], \"start\": [[37], [51]], \"entity_id\": [\"T9\", \"T11\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"concomitant\"]], \"start\": [[25]], \"entity_id\": [\"T10\"]}, \"Drug\": {\"text\": [[\"linezolid\"], [\"meperidine\"]], \"start\": [[37], [51]], \"entity_id\": [\"T9\", \"T11\"]}}]}, \"Negated\": {\"text\": [[\"not\"]], \"start\": [[74]], \"entity_id\": [\"T12\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"presented\"]], \"start\": [[4]], \"entity_id\": [\"T8\"]}, \"Treatment\": {\"text\": [[\"addition of ciprofloxacin to her current regimen of medications, which included digoxin\"]], \"start\": [[70]], \"entity_id\": [\"T9\"], \"Time_elapsed\": {\"text\": [[\"within a few days\"]], \"start\": [[49]], \"entity_id\": [\"T13\"]}, \"Drug\": {\"text\": [[\"ciprofloxacin\"], [\"digoxin\"]], \"start\": [[82], [150]], \"entity_id\": [\"T14\", \"T15\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"addition\"]], \"start\": [[70]], \"entity_id\": [\"T16\"]}, \"Drug\": {\"text\": [[\"ciprofloxacin\"], [\"digoxin\"]], \"start\": [[82], [150]], \"entity_id\": [\"T14\", \"T15\"]}}]}, \"Effect\": {\"text\": [[\"nausea and anorexia\"]], \"start\": [[29]], \"entity_id\": [\"T10\"]}, \"Subject\": {\"text\": [[\"She\"]], \"start\": [[0]], \"entity_id\": [\"T11\"], \"Gender\": {\"text\": [[\"She\"]], \"start\": [[0]], \"entity_id\": [\"T12\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[11]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"an active duty soldier\"]], \"start\": [[48]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"Disulfiram\"]], \"start\": [[0]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"Disulfiram\"]], \"start\": [[0]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"fulminant hepatic failure\"]], \"start\": [[19]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"treated\"]], \"start\": [[96]], \"entity_id\": [\"T9\"]}, \"Subject\": {\"text\": [[\"six cases\", \"patients with akinetic-rigid syndromes\"]], \"start\": [[22, 48]], \"entity_id\": [\"T7\"], \"Population\": {\"text\": [[\"six\"]], \"start\": [[22]], \"entity_id\": [\"T11\"]}, \"Disorder\": {\"text\": [[\"akinetic-rigid syndromes\"]], \"start\": [[62]], \"entity_id\": [\"T12\"]}}, \"Treatment\": {\"text\": [[\"risperidone\"]], \"start\": [[109]], \"entity_id\": [\"T10\"], \"Disorder\": {\"text\": [[\"psychosis\"]], \"start\": [[35]], \"entity_id\": [\"T8\"]}, \"Drug\": {\"text\": [[\"risperidone\"]], \"start\": [[109]], \"entity_id\": [\"T13\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"following\"]], \"start\": [[49]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"Colonic necrosis\"]], \"start\": [[0]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"Kayexalate (sodium polystryrene sulfonate) in sorbitol\"]], \"start\": [[81]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"Kayexalate\"], [\"sorbitol\"]], \"start\": [[81], [127]], \"entity_id\": [\"T7\", \"T8\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"in\"]], \"start\": [[124]], \"entity_id\": [\"T9\"]}, \"Drug\": {\"text\": [[\"sorbitol\"], [\"Kayexalate\"]], \"start\": [[127], [81]], \"entity_id\": [\"T8\", \"T7\"]}}]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"occur\"]], \"start\": [[82]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"Anaphylaxis\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"cisplatin\"]], \"start\": [[15]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"cisplatin\"]], \"start\": [[15]], \"entity_id\": [\"T7\"]}}, \"Subject\": {\"text\": [[\"patients\"]], \"start\": [[96]], \"entity_id\": [\"T5\"]}, \"Severity\": {\"text\": [[\"life-threatening\"]], \"start\": [[42]], \"entity_id\": [\"T8\"], \"value\": \"High\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[13]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"Piloerection\"]], \"start\": [[0]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"replacing fluvoxamine with milnacipran\"]], \"start\": [[24]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"milnacipran\"], [\"fluvoxamine\"]], \"start\": [[51], [34]], \"entity_id\": [\"T7\", \"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"treat\"]], \"start\": [[56]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"Ethambutol\"]], \"start\": [[0]], \"entity_id\": [\"T7\"], \"Disorder\": {\"text\": [[\"tuberculosis\"]], \"start\": [[62]], \"entity_id\": [\"T6\"]}, \"Drug\": {\"text\": [[\"Ethambutol\"]], \"start\": [[0]], \"entity_id\": [\"T9\"]}}, \"Speculated\": {\"text\": [[\"frequently\"]], \"start\": [[42]], \"entity_id\": [\"T8\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"complication\"]], \"start\": [[151]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"DIC\"]], \"start\": [[110]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"anti-D IGIV\"]], \"start\": [[167]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"anti-D IGIV\"]], \"start\": [[167]], \"entity_id\": [\"T6\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"during\"]], \"start\": [[158]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"transient episodes of thyrotoxicosis\"]], \"start\": [[121]], \"entity_id\": [\"T3\"]}, \"Subject\": {\"text\": [[\"Four Chinese female patients who suffered from manic-depressive disorder and underlying autoimmune thyroiditis\"]], \"start\": [[0]], \"entity_id\": [\"T5\"], \"Population\": {\"text\": [[\"Four\"]], \"start\": [[0]], \"entity_id\": [\"T8\"]}, \"Race\": {\"text\": [[\"Chinese\"]], \"start\": [[5]], \"entity_id\": [\"T9\"]}, \"Gender\": {\"text\": [[\"female\"]], \"start\": [[13]], \"entity_id\": [\"T10\"]}, \"Disorder\": {\"text\": [[\"underlying autoimmune thyroiditis\"]], \"start\": [[77]], \"entity_id\": [\"T1\"]}}, \"Treatment\": {\"text\": [[\"maintenance lithium therapy\"]], \"start\": [[165]], \"entity_id\": [\"T7\"], \"Disorder\": {\"text\": [[\"manic-depressive disorder\"]], \"start\": [[47]], \"entity_id\": [\"T11\"]}, \"Drug\": {\"text\": [[\"lithium\"]], \"start\": [[177]], \"entity_id\": [\"T12\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"caused\"]], \"start\": [[63]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"raised intracranial pressure\"]], \"start\": [[34]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"valproic acid\"]], \"start\": [[80]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"valproic acid\"]], \"start\": [[80]], \"entity_id\": [\"T6\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"in\"]], \"start\": [[38]], \"entity_id\": [\"T1\"]}, \"Subject\": {\"text\": [[\"patient with juvenile rheumatoid arthritis\"]], \"start\": [[41]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"low dose Methotrexate\"]], \"start\": [[97]], \"entity_id\": [\"T9\"], \"Disorder\": {\"text\": [[\"juvenile rheumatoid arthritis\"]], \"start\": [[54]], \"entity_id\": [\"T11\"]}, \"Drug\": {\"text\": [[\"Methotrexate\"]], \"start\": [[106]], \"entity_id\": [\"T12\"]}, \"Dosage\": {\"text\": [[\"low dose\"]], \"start\": [[97]], \"entity_id\": [\"T2\"]}}, \"Effect\": {\"text\": [[\"Primary ovarian large B-cell lymphoma\"]], \"start\": [[0]], \"entity_id\": [\"T10\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[10]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"carbamazepine\"]], \"start\": [[21]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"carbamazepine\"]], \"start\": [[21]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"Asterixis\"]], \"start\": [[0]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"with\"]], \"start\": [[39]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"tubulopathies\"]], \"start\": [[57]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"Ifosfamide\"]], \"start\": [[0]], \"entity_id\": [\"T7\"], \"Drug\": {\"text\": [[\"Ifosfamide\"]], \"start\": [[0]], \"entity_id\": [\"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"by\"]], \"start\": [[41]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"ethanolamine oleate\"]], \"start\": [[44]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"ethanolamine oleate\"]], \"start\": [[44]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"noncardiogenic pulmonary edema\"]], \"start\": [[10]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"A case\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[71]], \"entity_id\": [\"T4\"]}, \"Subject\": {\"text\": [[\"A boy with chronic neutropenia and recurrent inflammatory skin lesions\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Gender\": {\"text\": [[\"boy\"]], \"start\": [[2]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"multiple erythematous nodules\"]], \"start\": [[81]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"G-CSF\"]], \"start\": [[139]], \"entity_id\": [\"T6\"], \"Disorder\": {\"text\": [[\"chronic neutropenia and recurrent inflammatory skin lesions\"]], \"start\": [[11]], \"entity_id\": [\"T9\"]}, \"Drug\": {\"text\": [[\"G-CSF\"]], \"start\": [[139]], \"entity_id\": [\"T10\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"due\"]], \"start\": [[49]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"propylthiouracil\"]], \"start\": [[56]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"propylthiouracil\"]], \"start\": [[56]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"Fulminant hepatitis\"], [\"lymphocyte sensitization\"]], \"start\": [[0], [24]], \"entity_id\": [\"T4\", \"T5\"]}, \"Severity\": {\"text\": [[\"Fulminant\"]], \"start\": [[0]], \"entity_id\": [\"T8\"], \"value\": \"High\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"with\"]], \"start\": [[102]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"three patients with acute schizophrenia\"]], \"start\": [[13]], \"entity_id\": [\"T3\"], \"Population\": {\"text\": [[\"three\"]], \"start\": [[13]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"akathisia\"]], \"start\": [[75]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"olanzapine (20-25 mg/d)\"]], \"start\": [[107]], \"entity_id\": [\"T6\"], \"Disorder\": {\"text\": [[\"acute schizophrenia\"]], \"start\": [[33]], \"entity_id\": [\"T8\"]}, \"Drug\": {\"text\": [[\"olanzapine\"]], \"start\": [[107]], \"entity_id\": [\"T9\"]}, \"Dosage\": {\"text\": [[\"20-25 mg/d\"]], \"start\": [[119]], \"entity_id\": [\"T10\"]}}, \"Severity\": {\"text\": [[\"severe\"]], \"start\": [[68]], \"entity_id\": [\"T12\"], \"value\": \"High\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"cause\"]], \"start\": [[60]], \"entity_id\": [\"T10\"]}, \"Treatment\": {\"text\": [[\"insulin and glucose\"]], \"start\": [[40]], \"entity_id\": [\"T9\"], \"Drug\": {\"text\": [[\"glucose\"], [\"insulin\"]], \"start\": [[52], [40]], \"entity_id\": [\"T13\", \"T14\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"and\"]], \"start\": [[48]], \"entity_id\": [\"T12\"]}, \"Drug\": {\"text\": [[\"insulin\"], [\"glucose\"]], \"start\": [[40], [52]], \"entity_id\": [\"T14\", \"T13\"]}}]}, \"Effect\": {\"text\": [[\"renal and ocular vasodilation\"]], \"start\": [[66]], \"entity_id\": [\"T11\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"relationship to\"]], \"start\": [[15]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"capecitabine\"]], \"start\": [[31]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"capecitabine\"]], \"start\": [[31]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"headache\"]], \"start\": [[79]], \"entity_id\": [\"T3\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[41]], \"entity_id\": [\"T7\"]}, \"Subject\": {\"text\": [[\"a case\"]], \"start\": [[20]], \"entity_id\": [\"T3\"]}, \"Effect\": {\"text\": [[\"anuric ARF\"]], \"start\": [[30]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"high-dose mannitol infusion\"]], \"start\": [[47]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"mannitol\"]], \"start\": [[57]], \"entity_id\": [\"T8\"]}, \"Route\": {\"text\": [[\"infusion\"]], \"start\": [[66]], \"entity_id\": [\"T9\"]}, \"Dosage\": {\"text\": [[\"high-dose\"]], \"start\": [[47]], \"entity_id\": [\"T10\"]}, \"Disorder\": {\"text\": [[\"narrow-angle glaucoma\"]], \"start\": [[92]], \"entity_id\": [\"T11\"]}}, \"Speculated\": {\"text\": [[\"readily\"]], \"start\": [[119]], \"entity_id\": [\"T12\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"treated\"]], \"start\": [[8]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"She\"]], \"start\": [[0]], \"entity_id\": [\"T4\"], \"Gender\": {\"text\": [[\"She\"]], \"start\": [[0]], \"entity_id\": [\"T7\"]}}, \"Treatment\": {\"text\": [[\"sorafenib at 400 mg daily\"]], \"start\": [[21]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"sorafenib\"]], \"start\": [[21]], \"entity_id\": [\"T8\"]}, \"Dosage\": {\"text\": [[\"400 mg\"]], \"start\": [[34]], \"entity_id\": [\"T9\"]}, \"Freq\": {\"text\": [[\"daily\"]], \"start\": [[41]], \"entity_id\": [\"T10\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"provoked\"]], \"start\": [[85]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"recombinant alpha-2b peginterferon plus ribavirin\"]], \"start\": [[35]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"recombinant alpha-2b peginterferon\"], [\"ribavirin\"]], \"start\": [[35], [75]], \"entity_id\": [\"T7\", \"T9\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"plus\"]], \"start\": [[70]], \"entity_id\": [\"T8\"]}, \"Drug\": {\"text\": [[\"ribavirin\"], [\"recombinant alpha-2b peginterferon\"]], \"start\": [[75], [35]], \"entity_id\": [\"T9\", \"T7\"]}}]}, \"Effect\": {\"text\": [[\"type 1 diabetes mellitus\"]], \"start\": [[94]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"following\"]], \"start\": [[15]], \"entity_id\": [\"T3\"]}, \"Effect\": {\"text\": [[\"Rhabdomyolysis\"]], \"start\": [[0]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"clarithromycin monotherapy\"]], \"start\": [[25]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"clarithromycin\"]], \"start\": [[25]], \"entity_id\": [\"T6\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"effect on\"]], \"start\": [[25]], \"entity_id\": [\"T11\"]}, \"Effect\": {\"text\": [[\"gallbladder stasis\", \"alters bile acid composition and may thus hasten intrahepatic sludge and stone formation\"]], \"start\": [[35, 66]], \"entity_id\": [\"T9\"]}, \"Treatment\": {\"text\": [[\"octreotide\"]], \"start\": [[55]], \"entity_id\": [\"T10\"], \"Drug\": {\"text\": [[\"octreotide\"]], \"start\": [[55]], \"entity_id\": [\"T12\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[52]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"17-year-old boy with acute lymphoblastic leukemia\"]], \"start\": [[2]], \"entity_id\": [\"T3\"], \"Age\": {\"text\": [[\"17-year-old\"]], \"start\": [[2]], \"entity_id\": [\"T8\"]}, \"Gender\": {\"text\": [[\"boy\"]], \"start\": [[14]], \"entity_id\": [\"T9\"]}}, \"Effect\": {\"text\": [[\"acute renal failure\"]], \"start\": [[62]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"intravenous high-dose methotrexate (5 g/m2) infusion\"]], \"start\": [[100]], \"entity_id\": [\"T7\"], \"Route\": {\"text\": [[\"intravenous\"]], \"start\": [[100]], \"entity_id\": [\"T10\"]}, \"Drug\": {\"text\": [[\"methotrexate\"]], \"start\": [[122]], \"entity_id\": [\"T11\"]}, \"Dosage\": {\"text\": [[\"5 g/m2\"]], \"start\": [[136]], \"entity_id\": [\"T12\"]}, \"Time_elapsed\": {\"text\": [[\"within 48 h\"]], \"start\": [[82]], \"entity_id\": [\"T13\"]}, \"Disorder\": {\"text\": [[\"acute lymphoblastic leukemia\"]], \"start\": [[23]], \"entity_id\": [\"T14\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"complication of\"]], \"start\": [[22]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"Splenic hemorrhage\"]], \"start\": [[0]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"tissue plasminogen activator treatment\"]], \"start\": [[38]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"tissue plasminogen activator\"]], \"start\": [[38]], \"entity_id\": [\"T7\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"cause\"]], \"start\": [[38]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"Cefazolin\"]], \"start\": [[13]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"Cefazolin\"]], \"start\": [[13]], \"entity_id\": [\"T8\"]}}, \"Subject\": {\"text\": [[\"patient\"]], \"start\": [[52]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"leukopenia\"]], \"start\": [[62]], \"entity_id\": [\"T7\"]}, \"Speculated\": {\"text\": [[\"probable\"]], \"start\": [[29]], \"entity_id\": [\"T4\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"following\"]], \"start\": [[48]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Paradoxical cerebral cortical hyperexcitability\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"flupirtine overdose\"]], \"start\": [[58]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"flupirtine\"]], \"start\": [[58]], \"entity_id\": [\"T6\"]}, \"Dosage\": {\"text\": [[\"overdose\"]], \"start\": [[69]], \"entity_id\": [\"T7\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"found\"]], \"start\": [[46]], \"entity_id\": [\"T8\"]}, \"Effect\": {\"text\": [[\"herpesvirus infection\"]], \"start\": [[20]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"four leukemic patients\"]], \"start\": [[74]], \"entity_id\": [\"T6\"], \"Population\": {\"text\": [[\"four\"]], \"start\": [[74]], \"entity_id\": [\"T10\"]}}, \"Treatment\": {\"text\": [[\"large doses of cytarabine\"]], \"start\": [[114]], \"entity_id\": [\"T7\"], \"Drug\": {\"text\": [[\"cytarabine (cytosine arabinoside; Ara-C)\"]], \"start\": [[129]], \"entity_id\": [\"T11\"]}, \"Disorder\": {\"text\": [[\"leukemic\"]], \"start\": [[79]], \"entity_id\": [\"T12\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[8]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"Heparin\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"Heparin\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"hyperkalemia\"]], \"start\": [[16]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"hazards\"]], \"start\": [[86]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"DCF\"]], \"start\": [[112]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"DCF\"]], \"start\": [[112]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"myelosuppression\", \"immunosuppression and superinfection\"]], \"start\": [[9, 35]], \"entity_id\": [\"T6\"]}, \"Severity\": {\"text\": [[\"mild\"]], \"start\": [[29]], \"entity_id\": [\"T9\"], \"value\": \"Low\"}, \"Speculated\": {\"text\": [[\"potential\"]], \"start\": [[76]], \"entity_id\": [\"T10\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[46]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"withdrawal of quinine\"]], \"start\": [[56]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"quinine\"]], \"start\": [[70]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"photosensitivity is still present 3 years\"]], \"start\": [[4]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"by\"]], \"start\": [[36]], \"entity_id\": [\"T3\"]}, \"Effect\": {\"text\": [[\"Interference with the cortisol axis\"]], \"start\": [[0]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"CPH82\"]], \"start\": [[67]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"CPH82\"]], \"start\": [[67]], \"entity_id\": [\"T6\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"development\"]], \"start\": [[92]], \"entity_id\": [\"T3\"]}, \"Effect\": {\"text\": [[\"subfascial hemorrhage\"]], \"start\": [[107]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"alteplase\"]], \"start\": [[74]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"alteplase\"]], \"start\": [[74]], \"entity_id\": [\"T8\"]}}, \"Speculated\": {\"text\": [[\"possible\"]], \"start\": [[34]], \"entity_id\": [\"T6\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"triggered\"]], \"start\": [[109]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"phenobarbital\"]], \"start\": [[122]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"phenobarbital\"]], \"start\": [[122]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"an autoimmune cell-mediated hypersensitivity reaction\"]], \"start\": [[55]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"to\"]], \"start\": [[22]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Anaphylactic reaction\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"oral prednisone\"]], \"start\": [[25]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"prednisone\"]], \"start\": [[30]], \"entity_id\": [\"T6\"]}, \"Route\": {\"text\": [[\"oral\"]], \"start\": [[25]], \"entity_id\": [\"T7\"]}}, \"Subject\": {\"text\": [[\"a case\"]], \"start\": [[42]], \"entity_id\": [\"T8\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"in\"]], \"start\": [[45]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"flutamide\"]], \"start\": [[48]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"flutamide\"]], \"start\": [[48]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"Prolonged prostate-specific antigen response\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"received\"]], \"start\": [[128]], \"entity_id\": [\"T8\"]}, \"Effect\": {\"text\": [[\"cardiac arrest\"]], \"start\": [[94]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"doxorubicin\"]], \"start\": [[137]], \"entity_id\": [\"T7\"], \"Drug\": {\"text\": [[\"doxorubicin\"]], \"start\": [[137]], \"entity_id\": [\"T9\"]}}, \"Subject\": {\"text\": [[\"the patient\"]], \"start\": [[116]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"occurred\"]], \"start\": [[31]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"IDDM\"]], \"start\": [[20]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"interferon therapy\"]], \"start\": [[47]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"interferon\"]], \"start\": [[47]], \"entity_id\": [\"T7\"]}, \"Disorder\": {\"text\": [[\"chronic hepatitis.\"]], \"start\": [[70]], \"entity_id\": [\"T8\"]}}, \"Subject\": {\"text\": [[\"a case\"]], \"start\": [[10]], \"entity_id\": [\"T9\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[139]], \"entity_id\": [\"T9\"]}, \"Treatment\": {\"text\": [[\"nevirapine\"]], \"start\": [[128]], \"entity_id\": [\"T8\"], \"Drug\": {\"text\": [[\"nevirapine\"]], \"start\": [[128]], \"entity_id\": [\"T13\"]}, \"Disorder\": {\"text\": [[\"HIV\"]], \"start\": [[62]], \"entity_id\": [\"T14\"]}}, \"Effect\": {\"text\": [[\"SJS\"]], \"start\": [[150]], \"entity_id\": [\"T10\"]}, \"Subject\": {\"text\": [[\"patients with HIV\"]], \"start\": [[48]], \"entity_id\": [\"T11\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"resulting\"]], \"start\": [[49]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"baclofen withdrawal syndrome\"]], \"start\": [[20]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"oral baclofen underdosing\"]], \"start\": [[64]], \"entity_id\": [\"T6\"], \"Route\": {\"text\": [[\"oral\"]], \"start\": [[64]], \"entity_id\": [\"T7\"]}, \"Drug\": {\"text\": [[\"baclofen\"]], \"start\": [[69]], \"entity_id\": [\"T8\"]}, \"Dosage\": {\"text\": [[\"underdosing\"]], \"start\": [[78]], \"entity_id\": [\"T9\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[99]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"a month of therapy with enalapril\"]], \"start\": [[105]], \"entity_id\": [\"T4\"], \"Disorder\": {\"text\": [[\"nephrotic\"]], \"start\": [[14]], \"entity_id\": [\"T8\"]}, \"Duration\": {\"text\": [[\"a month\"]], \"start\": [[105]], \"entity_id\": [\"T10\"]}, \"Drug\": {\"text\": [[\"enalapril\"]], \"start\": [[129]], \"entity_id\": [\"T11\"]}}, \"Effect\": {\"text\": [[\"acute renal failure with serum creatinine to 1543 micromol/l\"]], \"start\": [[38]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"A 35-year-old nephrotic man\"]], \"start\": [[0]], \"entity_id\": [\"T6\"], \"Age\": {\"text\": [[\"35-year-old\"]], \"start\": [[2]], \"entity_id\": [\"T7\"]}, \"Gender\": {\"text\": [[\"man\"]], \"start\": [[24]], \"entity_id\": [\"T9\"]}}, \"Severity\": {\"text\": [[\"acute\"]], \"start\": [[38]], \"entity_id\": [\"T12\"], \"value\": \"High\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"been reported\"]], \"start\": [[79]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"propranolol\"]], \"start\": [[129]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"propranolol\"]], \"start\": [[129]], \"entity_id\": [\"T9\"]}}, \"Effect\": {\"text\": [[\"disorientation and temporary amnesia\"]], \"start\": [[36]], \"entity_id\": [\"T6\"]}, \"Subject\": {\"text\": [[\"patients\"]], \"start\": [[96]], \"entity_id\": [\"T8\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[113]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"oxcarbazepine\"]], \"start\": [[128]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"oxcarbazepine\"]], \"start\": [[128]], \"entity_id\": [\"T10\"]}}, \"Effect\": {\"text\": [[\"severe rash and systemic symptoms\"]], \"start\": [[79]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"a 13-year-old boy\"]], \"start\": [[42]], \"entity_id\": [\"T6\"], \"Age\": {\"text\": [[\"13-year-old\"]], \"start\": [[44]], \"entity_id\": [\"T7\"]}, \"Gender\": {\"text\": [[\"boy\"]], \"start\": [[56]], \"entity_id\": [\"T8\"]}}, \"Severity\": {\"text\": [[\"severe\"]], \"start\": [[79]], \"entity_id\": [\"T9\"], \"value\": \"Medium\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[13]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Renal damage\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"lithium carbonate\"]], \"start\": [[46]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"lithium carbonate.\"]], \"start\": [[46]], \"entity_id\": [\"T6\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[24]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"Triamcinolone acetonide\", \"coadministration of nefazodone\"]], \"start\": [[0, 105]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"Triamcinolone acetonide\"], [\"nefazodone\"]], \"start\": [[0], [125]], \"entity_id\": [\"T9\", \"T10\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"coadministration\"]], \"start\": [[105]], \"entity_id\": [\"T11\"]}, \"Drug\": {\"text\": [[\"nefazodone\"], [\"Triamcinolone acetonide\"]], \"start\": [[125], [0]], \"entity_id\": [\"T10\", \"T9\"]}}]}, \"Effect\": {\"text\": [[\"secondary adrenal insufficiency\"]], \"start\": [[32]], \"entity_id\": [\"T8\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"following\"]], \"start\": [[22]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"a child\"]], \"start\": [[81]], \"entity_id\": [\"T3\"], \"Age\": {\"text\": [[\"child\"]], \"start\": [[83]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"Hepatocellular damage\"]], \"start\": [[0]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"intravenous iron sucrose infusion\"]], \"start\": [[44]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"iron sucrose\"]], \"start\": [[56]], \"entity_id\": [\"T8\"]}, \"Route\": {\"text\": [[\"intravenous\", \"infusion\"]], \"start\": [[44, 69]], \"entity_id\": [\"T9\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[34]], \"entity_id\": [\"T11\"]}, \"Subject\": {\"text\": [[\"a 43-year-old woman\"]], \"start\": [[10]], \"entity_id\": [\"T10\"], \"Age\": {\"text\": [[\"43-year-old\"]], \"start\": [[12]], \"entity_id\": [\"T15\"]}, \"Gender\": {\"text\": [[\"woman\"]], \"start\": [[24]], \"entity_id\": [\"T16\"]}}, \"Effect\": {\"text\": [[\"sore throat, swelling of the lips and oral cavity and dysphagia\"]], \"start\": [[44]], \"entity_id\": [\"T12\"]}, \"Treatment\": {\"text\": [[\"2 weeks after the use of budesonide spray (Budefat)\"]], \"start\": [[109]], \"entity_id\": [\"T13\"], \"Time_elapsed\": {\"text\": [[\"2 weeks after\"]], \"start\": [[109]], \"entity_id\": [\"T17\"]}, \"Drug\": {\"text\": [[\"budesonide\"], [\"Budefat\"]], \"start\": [[134], [152]], \"entity_id\": [\"T18\", \"T19\"]}, \"Disorder\": {\"text\": [[\"bronchial asthma.\"]], \"start\": [[178]], \"entity_id\": [\"T20\"]}, \"Route\": {\"text\": [[\"spray\"]], \"start\": [[145]], \"entity_id\": [\"T21\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"appear to\"]], \"start\": [[36]], \"entity_id\": [\"T12\"]}, \"Treatment\": {\"text\": [[\"prescription of thiabendazole\", \"during the melarsoprol cure\"]], \"start\": [[76, 132]], \"entity_id\": [\"T9\"], \"Drug\": {\"text\": [[\"thiabendazole\"], [\"melarsoprol\"]], \"start\": [[92], [143]], \"entity_id\": [\"T13\", \"T15\"]}, \"Disorder\": {\"text\": [[\"strongyloidiasis\"]], \"start\": [[115]], \"entity_id\": [\"T14\"]}}, \"Effect\": {\"text\": [[\"increase the risk of ARE\"]], \"start\": [[46]], \"entity_id\": [\"T10\"]}, \"Speculated\": {\"text\": [[\"appear to\"]], \"start\": [[36]], \"entity_id\": [\"T16\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"of\"]], \"start\": [[84]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"amiodarone\"]], \"start\": [[87]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"amiodarone\"]], \"start\": [[87]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"pneumonitis\"]], \"start\": [[98]], \"entity_id\": [\"T4\"]}}" }, { "event_id": "E2", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E2\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"recovery\"]], \"start\": [[203]], \"entity_id\": [\"T12\"]}, \"Treatment\": {\"text\": [[\"immediate withdrawal of amiodarone, and prompt but continued steroid therapy\"]], \"start\": [[111]], \"entity_id\": [\"T9\"], \"Disorder\": {\"text\": [[\"pneumonitis\"]], \"start\": [[98]], \"entity_id\": [\"T8\"]}, \"Drug\": {\"text\": [[\"steroid\"], [\"amiodarone\"]], \"start\": [[172], [135]], \"entity_id\": [\"T10\", \"T11\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"increasing\"]], \"start\": [[90]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"hepatic toxicity\"]], \"start\": [[105]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"interaction between clarithromycin and isradipine\"]], \"start\": [[27]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"clarithromycin\"], [\"isradipine\"]], \"start\": [[47], [66]], \"entity_id\": [\"T10\", \"T11\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"interaction\"]], \"start\": [[27]], \"entity_id\": [\"T9\"]}, \"Drug\": {\"text\": [[\"clarithromycin\"], [\"isradipine\"]], \"start\": [[47], [66]], \"entity_id\": [\"T10\", \"T11\"]}}]}, \"Speculated\": {\"text\": [[\"potentially\"]], \"start\": [[78]], \"entity_id\": [\"T8\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"secondary\"]], \"start\": [[63]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"intraventricular administration of vancomycin\"]], \"start\": [[80]], \"entity_id\": [\"T6\"], \"Route\": {\"text\": [[\"intraventricular\"]], \"start\": [[80]], \"entity_id\": [\"T10\"]}, \"Drug\": {\"text\": [[\"vancomycin\"]], \"start\": [[115]], \"entity_id\": [\"T11\"]}}, \"Effect\": {\"text\": [[\"cerebrospinal fluid eosinophilia (CSFE)\"]], \"start\": [[23]], \"entity_id\": [\"T9\"]}, \"Subject\": {\"text\": [[\"two cases\"]], \"start\": [[10]], \"entity_id\": [\"T1\"], \"Population\": {\"text\": [[\"two\"]], \"start\": [[10]], \"entity_id\": [\"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"experienced\"]], \"start\": [[29]], \"entity_id\": [\"T10\"]}, \"Subject\": {\"text\": [[\"two patients\"]], \"start\": [[12]], \"entity_id\": [\"T8\"], \"Population\": {\"text\": [[\"two\"]], \"start\": [[12]], \"entity_id\": [\"T13\"]}}, \"Effect\": {\"text\": [[\"serious quetiapine adverse effects\"]], \"start\": [[41]], \"entity_id\": [\"T11\"]}, \"Treatment\": {\"text\": [[\"ritonavir-boosted atazanavir\"]], \"start\": [[125]], \"entity_id\": [\"T12\"], \"Drug\": {\"text\": [[\"ritonavir\"], [\"atazanavir\"]], \"start\": [[125], [143]], \"entity_id\": [\"T14\", \"T16\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"interaction\"]], \"start\": [[108]], \"entity_id\": [\"T15\"]}, \"Drug\": {\"text\": [[\"ritonavir\"], [\"atazanavir\"]], \"start\": [[125], [143]], \"entity_id\": [\"T14\", \"T16\"]}}]}, \"Speculated\": {\"text\": [[\"potentially\"]], \"start\": [[76]], \"entity_id\": [\"T9\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"related\"]], \"start\": [[54]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"ritonavir\"]], \"start\": [[85]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"ritonavir\"]], \"start\": [[85]], \"entity_id\": [\"T8\"]}}, \"Subject\": {\"text\": [[\"patient\"]], \"start\": [[4]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"carbamazepine toxicity\"]], \"start\": [[31]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"lead\"]], \"start\": [[190]], \"entity_id\": [\"T10\"]}, \"Subject\": {\"text\": [[\"patients\"]], \"start\": [[43]], \"entity_id\": [\"T8\"]}, \"Treatment\": {\"text\": [[\"fentanyl\"]], \"start\": [[114]], \"entity_id\": [\"T9\"], \"Drug\": {\"text\": [[\"voriconazole\"], [\"fluconazole\"], [\"fentanyl\"]], \"start\": [[66], [82], [163]], \"entity_id\": [\"T12\", \"T13\", \"T15\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"during\"]], \"start\": [[94]], \"entity_id\": [\"T14\"]}, \"Drug\": {\"text\": [[\"voriconazole\"], [\"fluconazole\"]], \"start\": [[66], [82]], \"entity_id\": [\"T12\", \"T13\"]}}]}, \"Effect\": {\"text\": [[\"respiratory depression\"]], \"start\": [[198]], \"entity_id\": [\"T11\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"following\"]], \"start\": [[105]], \"entity_id\": [\"T9\"]}, \"Effect\": {\"text\": [[\"DIC associated with acute hemoglobinemia or hemoglobinuria\"]], \"start\": [[46]], \"entity_id\": [\"T8\"]}, \"Treatment\": {\"text\": [[\"anti-D IGIV administration\"]], \"start\": [[115]], \"entity_id\": [\"T10\"], \"Route\": {\"text\": [[\"IV administration\"]], \"start\": [[124]], \"entity_id\": [\"T7\"]}, \"Drug\": {\"text\": [[\"anti-D\"]], \"start\": [[115]], \"entity_id\": [\"T12\"]}, \"Disorder\": {\"text\": [[\"ITP\"]], \"start\": [[146]], \"entity_id\": [\"T13\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"results\"]], \"start\": [[200]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"Risperidone\"]], \"start\": [[0]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"Risperidone\"]], \"start\": [[0]], \"entity_id\": [\"T9\"]}}, \"Effect\": {\"text\": [[\"tardive dyskinesia\"]], \"start\": [[268]], \"entity_id\": [\"T8\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"became\"]], \"start\": [[21]], \"entity_id\": [\"T8\"]}, \"Subject\": {\"text\": [[\"A 5-month-old infant\"]], \"start\": [[0]], \"entity_id\": [\"T5\"], \"Age\": {\"text\": [[\"5-month-old\"], [\"infant\"]], \"start\": [[2], [14]], \"entity_id\": [\"T11\", \"T12\"]}}, \"Effect\": {\"text\": [[\"lethargic and poorly responsive\"]], \"start\": [[28]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"receiving 1 drop of brimonidine in each eye\"]], \"start\": [[66]], \"entity_id\": [\"T7\"], \"Drug\": {\"text\": [[\"brimonidine\"]], \"start\": [[86]], \"entity_id\": [\"T9\"]}, \"Dosage\": {\"text\": [[\"1 drop\"]], \"start\": [[76]], \"entity_id\": [\"T10\"]}, \"Route\": {\"text\": [[\"in each eye\"]], \"start\": [[98]], \"entity_id\": [\"T13\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[43]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"renal damage\"]], \"start\": [[30]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"lithium carbonate treatment\"]], \"start\": [[59]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"lithium carbonate\"]], \"start\": [[59]], \"entity_id\": [\"T8\"]}}, \"Subject\": {\"text\": [[\"2 cases\"]], \"start\": [[19]], \"entity_id\": [\"T6\"], \"Population\": {\"text\": [[\"2\"]], \"start\": [[19]], \"entity_id\": [\"T7\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"leading\"]], \"start\": [[90]], \"entity_id\": [\"T10\"]}, \"Treatment\": {\"text\": [[\"valproic acid may interfere with glucuronidation of lamotrigine\"]], \"start\": [[25]], \"entity_id\": [\"T8\"], \"Drug\": {\"text\": [[\"valproic acid\"], [\"lamotrigine\"]], \"start\": [[25], [77]], \"entity_id\": [\"T12\", \"T13\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"interfere\"]], \"start\": [[43]], \"entity_id\": [\"T11\"]}, \"Drug\": {\"text\": [[\"valproic acid\"], [\"lamotrigine\"]], \"start\": [[25], [77]], \"entity_id\": [\"T12\", \"T13\"]}}]}, \"Effect\": {\"text\": [[\"increased serum lamotrigine levels, or perhaps alter the drug's metabolism, resulting in accumulation of a toxic intermediate metabolite\"]], \"start\": [[101]], \"entity_id\": [\"T9\"]}, \"Speculated\": {\"text\": [[\"hypothesized\"]], \"start\": [[7]], \"entity_id\": [\"T7\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"during\"]], \"start\": [[86]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"continuous infusion of F VIII\"]], \"start\": [[93]], \"entity_id\": [\"T5\"], \"Disorder\": {\"text\": [[\"intramural jejunal bleeding\"]], \"start\": [[129]], \"entity_id\": [\"T11\"]}, \"Route\": {\"text\": [[\"continuous infusion\"]], \"start\": [[93]], \"entity_id\": [\"T9\"]}, \"Drug\": {\"text\": [[\"F VIII\"]], \"start\": [[116]], \"entity_id\": [\"T10\"]}}, \"Subject\": {\"text\": [[\"a patient with severe haemophilia A and F V G1691A mutation\"]], \"start\": [[26]], \"entity_id\": [\"T4\"], \"Disorder\": {\"text\": [[\"haemophilia A and F V G1691A mutation\"]], \"start\": [[48]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"Portal vein thrombosis\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}}" }, { "event_id": "E2", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E2\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"therapy\"]], \"start\": [[196]], \"entity_id\": [\"T1\"]}, \"Treatment\": {\"text\": [[\"heparin\"]], \"start\": [[188]], \"entity_id\": [\"T2\"], \"Disorder\": {\"text\": [[\"Portal vein thrombosis\"]], \"start\": [[0]], \"entity_id\": [\"T12\"]}, \"Drug\": {\"text\": [[\"heparin\"]], \"start\": [[188]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"successful thrombolysis\"]], \"start\": [[158]], \"entity_id\": [\"T13\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"exposed\"]], \"start\": [[28]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"incapacitating isolated idential sensory neuropathy\"]], \"start\": [[82]], \"entity_id\": [\"T3\"]}, \"Subject\": {\"text\": [[\"A healthy, 30-year-old man\"]], \"start\": [[0]], \"entity_id\": [\"T4\"], \"Age\": {\"text\": [[\"30-year-old\"]], \"start\": [[11]], \"entity_id\": [\"T7\"]}, \"Gender\": {\"text\": [[\"man\"]], \"start\": [[23]], \"entity_id\": [\"T8\"]}}, \"Treatment\": {\"text\": [[\"sulindac\"]], \"start\": [[39]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"sulindac\"]], \"start\": [[39]], \"entity_id\": [\"T9\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[11]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"Clofibrate\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Disorder\": {\"text\": [[\"diabetes insipidus\"]], \"start\": [[45]], \"entity_id\": [\"T7\"]}, \"Drug\": {\"text\": [[\"Clofibrate\"]], \"start\": [[0]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"myopathy\"]], \"start\": [[19]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"patients with diabetes insipidus\"]], \"start\": [[31]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"aggravated\"]], \"start\": [[65]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"NASH\"]], \"start\": [[51]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"raloxifene\"]], \"start\": [[79]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"raloxifene\"]], \"start\": [[79]], \"entity_id\": [\"T6\"]}}, \"Subject\": {\"text\": [[\"the first histologically confirmed case\"]], \"start\": [[8]], \"entity_id\": [\"T7\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"related\"]], \"start\": [[43]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"lamotrigine\"]], \"start\": [[54]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"lamotrigine\"]], \"start\": [[54]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"TEN\", \"SJS\"]], \"start\": [[24, 39]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[20]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"ARA-C\"]], \"start\": [[0]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"ARA-C\"]], \"start\": [[0]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"dermatologic toxicity\"]], \"start\": [[36]], \"entity_id\": [\"T7\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"to\"]], \"start\": [[55]], \"entity_id\": [\"T7\"]}, \"Effect\": {\"text\": [[\"Hyperglycemia and diabetic coma\"]], \"start\": [[0]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"propranolol\"]], \"start\": [[67]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"propranolol\"]], \"start\": [[67]], \"entity_id\": [\"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"occurrence\"]], \"start\": [[37]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"ischemic colitis\"]], \"start\": [[51]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"tegaserod\"]], \"start\": [[90]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"tegaserod\"]], \"start\": [[90]], \"entity_id\": [\"T7\"]}}, \"Subject\": {\"text\": [[\"patients\"]], \"start\": [[71]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"to\"]], \"start\": [[12]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"Anaphylaxis\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"intravenous cyclosporine\"]], \"start\": [[15]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"cyclosporine\"]], \"start\": [[27]], \"entity_id\": [\"T6\"]}, \"Route\": {\"text\": [[\"intravenous\"]], \"start\": [[15]], \"entity_id\": [\"T7\"]}}, \"Subject\": {\"text\": [[\"case\"]], \"start\": [[76]], \"entity_id\": [\"T8\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"presented\"]], \"start\": [[64]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"A woman of 80 years\"]], \"start\": [[13]], \"entity_id\": [\"T3\"], \"Gender\": {\"text\": [[\"woman\"]], \"start\": [[15]], \"entity_id\": [\"T7\"]}, \"Age\": {\"text\": [[\"80 years\"]], \"start\": [[24]], \"entity_id\": [\"T8\"]}}, \"Treatment\": {\"text\": [[\"on long-term warfarin\"]], \"start\": [[34]], \"entity_id\": [\"T4\"], \"Duration\": {\"text\": [[\"long-term\"]], \"start\": [[37]], \"entity_id\": [\"T9\"]}, \"Drug\": {\"text\": [[\"warfarin\"]], \"start\": [[47]], \"entity_id\": [\"T10\"]}}, \"Effect\": {\"text\": [[\"acute dissecting thoracic aortic aneurysm\"]], \"start\": [[82]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[77]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"sudden cutaneous reaction\"]], \"start\": [[89]], \"entity_id\": [\"T7\"]}, \"Subject\": {\"text\": [[\"A patient with an allergy to a macrolide antibiotic\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Disorder\": {\"text\": [[\"allergy to a macrolide antibiotic\"]], \"start\": [[18]], \"entity_id\": [\"T8\"]}}, \"Treatment\": {\"text\": [[\"given tacrolimus\"]], \"start\": [[56]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"tacrolimus\"]], \"start\": [[62]], \"entity_id\": [\"T9\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"treated\"]], \"start\": [[104]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"extramedullary relapse\"]], \"start\": [[61]], \"entity_id\": [\"T3\"]}, \"Subject\": {\"text\": [[\"patients\"]], \"start\": [[87]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"ATRA\"]], \"start\": [[117]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"ATRA\"]], \"start\": [[117]], \"entity_id\": [\"T9\"]}}, \"Speculated\": {\"text\": [[\"suggests\"]], \"start\": [[10]], \"entity_id\": [\"T8\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[11]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"Olanzapine\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"Olanzapine\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"neuroleptic malignant syndrome\"]], \"start\": [[22]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[15]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Acute dystonia\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"lamivudine\"]], \"start\": [[26]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"lamivudine\"]], \"start\": [[26]], \"entity_id\": [\"T6\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[78]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"infliximab\"]], \"start\": [[51]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"infliximab\"]], \"start\": [[51]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"lupus-like clinical syndrome\"]], \"start\": [[86]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[24]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"Quetiapine\"]], \"start\": [[9]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"Quetiapine\"]], \"start\": [[9]], \"entity_id\": [\"T12\"]}}, \"Effect\": {\"text\": [[\"leucopenia\"]], \"start\": [[40]], \"entity_id\": [\"T7\"]}, \"Subject\": {\"text\": [[\"two patients\"]], \"start\": [[54]], \"entity_id\": [\"T8\"], \"Population\": {\"text\": [[\"two\"]], \"start\": [[54]], \"entity_id\": [\"T9\"]}}}" }, { "event_id": "E2", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E2\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[24]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"Quetiapine\"]], \"start\": [[9]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"Quetiapine\"]], \"start\": [[9]], \"entity_id\": [\"T12\"]}}, \"Effect\": {\"text\": [[\"clinically apparent agranulocytosis\"]], \"start\": [[71]], \"entity_id\": [\"T13\"]}, \"Subject\": {\"text\": [[\"one patient\"]], \"start\": [[110]], \"entity_id\": [\"T14\"], \"Population\": {\"text\": [[\"one\"]], \"start\": [[110]], \"entity_id\": [\"T10\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[76]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"Oral intake and acarbose\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"acarbose\"]], \"start\": [[16]], \"entity_id\": [\"T7\"]}, \"Route\": {\"text\": [[\"Oral intake\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"the ileus spontaneously resolved\"]], \"start\": [[43]], \"entity_id\": [\"T4\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"impeded\"]], \"start\": [[101]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"magnesium sulfate\"]], \"start\": [[73]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"magnesium sulfate\"]], \"start\": [[73]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"lactogenesis\"]], \"start\": [[109]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"increases\"]], \"start\": [[45]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"tamoxifen\"]], \"start\": [[35]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"tamoxifen\"]], \"start\": [[35]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"incidence of proliferative lesions of the endometrium\"]], \"start\": [[59]], \"entity_id\": [\"T4\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[22]], \"entity_id\": [\"T4\"]}, \"Subject\": {\"text\": [[\"Three senile patients\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Population\": {\"text\": [[\"Three\"]], \"start\": [[0]], \"entity_id\": [\"T7\"]}, \"Age\": {\"text\": [[\"senile\"]], \"start\": [[6]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"encephalopathy\"]], \"start\": [[44]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"calcium hopantenate\"]], \"start\": [[75]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"calcium hopantenate\"]], \"start\": [[75]], \"entity_id\": [\"T10\"]}}, \"Severity\": {\"text\": [[\"fatal\"]], \"start\": [[32]], \"entity_id\": [\"T9\"], \"value\": \"Medium\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"due\"]], \"start\": [[13]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Renal injury\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"anastrozole\"]], \"start\": [[20]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"anastrozole\"]], \"start\": [[20]], \"entity_id\": [\"T6\"]}}, \"Negated\": {\"text\": [[\"not\"]], \"start\": [[36]], \"entity_id\": [\"T7\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[79]], \"entity_id\": [\"T9\"]}, \"Treatment\": {\"text\": [[\"initiation of aripiprazole\"]], \"start\": [[89]], \"entity_id\": [\"T10\"], \"Time_elapsed\": {\"text\": [[\"five weeks\"]], \"start\": [[68]], \"entity_id\": [\"T11\"]}, \"Drug\": {\"text\": [[\"aripiprazole\"]], \"start\": [[103]], \"entity_id\": [\"T12\"]}}, \"Effect\": {\"text\": [[\"Facial, tongue, and arm movements\"]], \"start\": [[0]], \"entity_id\": [\"T8\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"due\"]], \"start\": [[23]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"Restless legs syndrome\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"interferon-alpha\"]], \"start\": [[30]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"interferon-alpha\"]], \"start\": [[30]], \"entity_id\": [\"T6\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"reported\"]], \"start\": [[13]], \"entity_id\": [\"T3\"]}, \"Effect\": {\"text\": [[\"HUS\"]], \"start\": [[0]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"several anticancer chemotherapies and most often after mitomycin C-based chemotherapy regimens\"]], \"start\": [[28]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"mitomycin C\"]], \"start\": [[83]], \"entity_id\": [\"T7\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"association\"]], \"start\": [[13]], \"entity_id\": [\"T11\"]}, \"Treatment\": {\"text\": [[\"sulfonamide class of antibiotics\"]], \"start\": [[49]], \"entity_id\": [\"T10\"], \"Drug\": {\"text\": [[\"sulfonamide class of antibiotics\"]], \"start\": [[49]], \"entity_id\": [\"T12\"]}, \"Disorder\": {\"text\": [[\"skin and soft tissue infections (SSTIs)\"]], \"start\": [[206]], \"entity_id\": [\"T13\"]}}, \"Effect\": {\"text\": [[\"SJS/TEN\"]], \"start\": [[33]], \"entity_id\": [\"T9\"]}, \"Subject\": {\"text\": [[\"CA-MRSA\"]], \"start\": [[132]], \"entity_id\": [\"T15\"], \"Disorder\": {\"text\": [[\"CA-MRSA\"]], \"start\": [[132]], \"entity_id\": [\"T14\"]}}}" } ] } ]